News from

Perelman School of Medicine

Visit the School's Site
Reset All Filters
2945 Results
New CAR T treatment opens doors for kidney patients
Anatomy of two kidneys

Image: jitendrajadhav via Getty Images

New CAR T treatment opens doors for kidney patients

An early Penn Medicine trial demonstrates CAR T cells can safely desensitize even the most challenging transplant candidates.

Matt Toal

2 min. read

GLP-1 use linked to lower breast cancer incidence in large cohort study
A person holding a GLP-1 applicator.

Image: Iuliia Burmistrova via Getty Images

GLP-1 use linked to lower breast cancer incidence in large cohort study

A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who take GLP-1 medications are about 30% less likely to develop breast cancer than those who do not take GLP-1 medications.

2 min. read

To deliver hospital-level care at home, practice makes perfect
Nurses practice how to talk to patients about properly storing medications

Nurses practice how to talk to patients about properly storing medications while they are enrolled in Hospital at Home.

(Image: Courtesy of Penn Medicine News)

To deliver hospital-level care at home, practice makes perfect

Years of planning come to fruition as Penn Medicine’s Hospital at Home teams test run a new era of patient care devoted to better outcomes and fewer readmissions.

From Penn Medicine News

2 min. read

Why is everything gambling now?
Hand holding a mobile phone with sports bets lined up.

Over the last decade, there’s been an explosion in phone-based gambling platforms owing to the 2018 Supreme Court ruling that struck down a federal sports betting ban. Neuroscientist Michael L. Platt says the gambling boom has as much to do with human biology as it does business. 

(Image: Hispanolist)

Why is everything gambling now?

Neuroscientist Michael Platt discusses the biological basis of gambling as it relates to the over proliferation of gambling-based platforms.

5 min. read

AI and healthcare innovation: Design with us, not just for us

AI and healthcare innovation: Design with us, not just for us

In May, Penn Washington partnered with the Penn Artificial Intelligence and Technology Collaboratory for Healthy Aging and Penn Nursing to examine the use of Artificial Intelligence tools to support aging and improve the quality of life of older adults and their families, including persons with Alzheimer’s disease and related dementias.

An AI tool to speed antibiotic discovery
Jacob R. Gardner, César de la Fuente and Marcelo Torres, holding a 3D-printed example of the kind of antibiotic peptide they generated

(From left) Co-authors Jacob R. Gardner, César de la Fuente and Marcelo Torres, holding a 3D-printed example of the kind of antibiotic peptide they generated using AI.

(Image: Sylvia Zhang)

An AI tool to speed antibiotic discovery

APEX is an AI model that predicts whether or not a given peptide is likely to have antimicrobial properties. Now, APEXGo can identify antibiotic candidates with laboratory activity against disease-causing bacteria, simply by searching large datasets.

Ian Scheffler

2 min. read

Major gaps in online info for patients about AI and cancer

Major gaps in online info for patients about AI and cancer

In a new Penn Medicine study, researchers screened web pages to understand how patients are using AI in their searches in an effort to work with the emerging technology to offer more accessible, high-quality resources.

Immune protein a possible target to slow Parkinson’s disease
Neuron cell network

Image: koto_feja via Getty Images

Immune protein a possible target to slow Parkinson’s disease

Researchers at Penn Medicine have found that blocking a key neuronal protein interrupts the spread of toxins to healthy neurons in preclinical studies.

Eric Horvath

1 min. read

Inside NSF AIRFoundry, Senator McCormick gets a look at the future of RNA discovery
Senator Dave McCormick (second from left) and Andrew Hanna (left) in the lab at AirFoundry.

Senator Dave McCormick (second from left) and Andrew Hanna (left) observing Hanna’s robotic system for rapidly formulating large numbers of lipid nanoparticles.

(Image: Sylvia Zhang)

Inside NSF AIRFoundry, Senator McCormick gets a look at the future of RNA discovery

A visit to Penn’s Artificial Intelligence-driven RNA BioFoundry gave U.S. Senator Dave McCormick a firsthand look at how federal investment in science translates into shared research infrastructure, student training, and regional economic development.

Ian Scheffler

2 min. read

Applying AI to accelerate discovery, foster learning

From left to right: Penn President J. Larry Jameson, Hamsa Bastani of the Wharton School, and César de la Fuente of Penn Medicine at the Annenberg Center for the Performing Arts. 

nocred

Applying AI to accelerate discovery, foster learning

At an Alumni Weekend panel moderated by President J. Larry Jameson, Presidential Associate Professor César de la Fuente of Penn Medicine and Hamsa Bastani of the Wharton School highlighted how research at Penn is putting AI insights and tools into practice.

3 min. read